This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Masson, J.-B. Articles by Webb, J. G. Search for Related Content PubMed Articles by Masson, J.-B. Articles by Webb, J. G. Related Collections Valvular heart disease Catheter-based coronary and valvular interventions: other

Contemporary Reviews in Interventional Cardiology

Percutaneous Treatment of Mitral Regurgitation

Jean-Bernard Masson, MD and John G. Webb, MD

From the St Paul’s Hospital, University of British Columbia, Vancouver, Canada.

Correspondence to John Webb, MD, McLeod Professor of Heart Valve Intervention, St Paul’s Hospital, 1081 Burrard Street, Vancouver, British Columbia, Canada V6Z 1Y6. E-mail webb@providencehealth.bc.ca

Key Words: mitral valve • regurgitation • valvuloplasty • catheter • percutaneous repair

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Percutaneous mitral valve therapy became a reality more than 25 years ago with the first description of balloon valvuloplasty for rheumatic mitral stenosis.¹ More recently, percutaneous closure of paravalvular leaks after surgical valve implantation has been shown to have a potential, but limited, role.^2–4 However, valvular mitral regurgitation (MR) remains largely the purview of surgery. Recently, the potential for less invasively replicating these successful surgical procedures without the need for thoracotomy or cardiopulmonary bypass has generated considerable interest. For the most part, these new approaches are modeled after established surgical strategies.

Percutaneous approaches to mitral repair can be broadly divided into procedures that address the various components of the mitral valve. For purposes of discussion, the mitral valve can be considered to have several component parts: leaflets, subvalvular apparatus (chordate tendinae and papillary muscles), annulus, left atrium, and left ventricle.⁵ All are integral to the normal function of the mitral valve and each is a potential avenue for repair. Although many such avenues may not lead to an effective surgical option, it may be unwise to dismiss the possibility that others will achieve some measure of success. We briefly review the current percutaneous therapies being developed and evaluated for the management of MR. The current status of various percutaneous therapies is presented in Table 1.

View this table:   Table 1. Current Status of Percutaneous Mitral Valve Repair Procedures

 
Leaflet Repair
Complex leaflet repair is currently beyond the reach of a percutaneous approach. However, the relatively simple but, in selected patients, effective "double-orifice" surgical repair . . . [Full Text of this Article]